Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CHKA | P35790 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30337153 | 0.88 | FAAH (0.48) | — | |
| SCHEMBL26092261 | 0.86 | KMT2A (0.41) | KMT2ADRD4ACHEPKMHTR1A | |
| SCHEMBL30337392 | 0.86 | ALDH1A1 (0.44) | LMNADDB1CRBN | |
| SCHEMBL30336976 | 0.86 | KMT2A (0.55) | KMT2ADRD4ACHEPKMHTR1A | |
| SCHEMBL30337129 | 0.84 | KMT2A (0.46) | KMT2ADRD4ACHEPKM | |
| SCHEMBL28980919 | 0.84 | KMT2A (0.46) | KMT2ADRD4ACHEPKM | |
| SCHEMBL30337060 | 0.83 | KMT2A (0.49) | KMT2ADRD4ACHEPKMHTR1A | |
| SCHEMBL30337128 | 0.81 | KMT2A (0.41) | MCHR1KCNH2KMT2ADRD4LMNA | |
| SCHEMBL30337305 | 0.80 | HTR1A (0.43) | KMT2AACHEPKMHTR1ACHKA | |
| SCHEMBL24153592 | 0.80 | KMT2A (0.38) | MCHR1KMT2AACHEPKMHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916206-A | Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same | 治愈医药社株式会社 | 2023-04-04 | — | — | CN | disclosed |